SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Roche Holding AG (RHHBF) 当前追踪市盈率 (P/E) 为 26.1, 前瞻市盈率为 20.6. 追踪盈利收益率为 3.84%, 前瞻盈利收益率 4.85%. PEG 0.47 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (60/100, 通过) — PEG ≤ 1.0 — Peter Lynch 低估标准 (0.47).
- 前瞻市盈率 20.6 (低于追踪值 26.1) — 分析师预计盈利将增长，这将改善估值。
- PEG 比率 0.47 — 低于1.0表明股票相对于其盈利增长率被低估（Peter Lynch 标准）。
- 追踪盈利收益率 3.84% — 与债券收益率（约4.3%）大致持平，风险回报适中。 前瞻收益率改善至 4.85% 随着盈利恢复。
SharesGrow 综合评分： 67/100 其中 4/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
60/100
Price-to-Earnings & upside
Proven by this page
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
估值概览 — RHHBF
估值倍数
P/E (TTM)26.1
前瞻 P/E20.6
PEG 比率0.47
前瞻 PEG0.78
P/B 比率0.00
P/S 比率5.46
EV/EBITDA0.0
每股数据
EPS (TTM)$16.05
前瞻 EPS（预估）$20.30
每股账面价值$0.00
每股营收$76.64
每股自由现金流$0.00
收益率与内在价值
盈利收益率3.84%
Forward Earnings Yield4.85%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$11.13 |
$50.58B |
$9.58B |
18.9% |
| 2017 |
$10.04 |
$53.3B |
$8.63B |
16.2% |
| 2018 |
$12.21 |
$56.85B |
$10.5B |
18.5% |
| 2019 |
$15.62 |
$61.47B |
$13.5B |
22% |
| 2020 |
$16.52 |
$58.32B |
$14.3B |
24.5% |
| 2021 |
$16.20 |
$62.8B |
$13.93B |
22.2% |
| 2022 |
$15.53 |
$63.28B |
$12.42B |
19.6% |
| 2023 |
$14.30 |
$60.44B |
$11.5B |
19% |
| 2024 |
$10.32 |
$62.4B |
$8.28B |
13.3% |
| 2025 |
$16.05 |
$61.55B |
$12.89B |
20.9% |
